Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices 40863 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 26, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16162 Filed 7–28–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; P41 NCBIB Review 

F–SEP. 

Date: October 25–26, 2021. 

Time: 09:00 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy II, 6707 Democracy Blvd., 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Dennis Hlasta, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Blvd., Bethesda, MD 20892, (301) 

451–3398, dennis.hlasta@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, National Institute of 

Biomedical Imaging and Bioengineering, 

National Institutes of Health, HHS) 

Dated: July 23, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16161 Filed 7–28–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

The National Institutes of Health (NIH) 

Scientific Workshop on Violence & 

Related Health Outcomes in Sexual & 

Gender Minority Communities Open 

Session 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Institutes of 

Health (NIH) will hold the Phase IV 

open session for the NIH Scientific 

Workshop on Violence and Related 

Health Outcomes in Sexual and Gender 

Minority (SGM) Communities to 

enhance our understanding of violence 

against SGM individuals and identify 

opportunities in violence-related 

research. The primary objectives of 

NIH’s Phase IV meeting are: (1) To allow 

the public to participate, and (2) to 

further refine research opportunities. 

DATES: The NIH Scientific Workshop on 

Violence and Related Health Outcomes 

in Sexual and Gender Minority 

Communities Phase IV virtual meeting 

will be held on Thursday, August 26, 

2021, from 12:00–4:00 p.m. Eastern 

Daylight Time (New York, GMT). 

ADDRESSES: The meeting will be held 

virtually via WebEx. 

The preliminary agenda and 

registration are available at https://

tinyurl.com/SGMwkshp. 

FOR FURTHER INFORMATION CONTACT: 

Irene Avila, Ph.D., Assistant Director, 

Sexual & Gender Minority Research 

Office (SGMRO), avilai@mail.nih.gov, 

301–594–9701. 

SUPPLEMENTARY INFORMATION: 

Background: ‘‘Sexual and gender 

minority’’ is an umbrella term that 

includes, but is not limited to, 

individuals who identify as lesbian, gay, 

bisexual, asexual, transgender, TwoSpirit, queer, and/or intersex. 

Individuals with same-sex or -gender 

attractions or behaviors and those with 

a difference in sex development are also 

included. These populations also 

encompass those who do not selfidentify with one of these terms but 

whose sexual orientation, gender 

identity or expression, or reproductive 

development is characterized by nonbinary constructs of sexual orientation, 

gender, and/or sex. 

In accordance with Section 404N of 

the 21st Century Cures Act (Pub. L. 114– 

255), the Director of NIH shall 

encourage research on SGM 

populations. The Sexual and Gender 

Minority Research Office (SGMRO) 

coordinates SGM-related research and 

activities by working directly with NIH 

Institutes, Centers, and Offices. The 

Office was officially established in 

September 2015 within the Division of 

Program Coordination, Planning, and 

Strategic Initiatives (DPCPSI) in the NIH 

Office of the Director and has the 

following operational goals: (1) Advance 

rigorous research on the health of SGM 

populations in both the extramural and 

intramural research communities; (2) 

expand SGM health research by 

fostering partnerships and 

collaborations with a strategic array of 

internal and external stakeholders; (3) 

foster a highly skilled and diverse 

workforce in SGM health research; and 

(4) encourage data collection related to 

SGM populations in research and the 

biomedical research workforce. The 

Scientific Workshop on Violence and 

Related Health Outcomes in Sexual and 

Gender Minority Communities 

represents an important step in 

pursuing these goals specifically in the 

field of violence research. 

The NIH Scientific Workshop on 

Violence and Related Health Outcomes 

in Sexual and Gender Minority 

Communities Phase IV Public Meeting 

Details 

The NIH Scientific Workshop on 

Violence and Related Health Outcomes 

in Sexual and Gender Minority 

Communities invites stakeholders 

throughout the scientific research 

community, clinical practice 

communities, patient and family 

advocates, scientific or professional 

organizations, federal partners, internal 

NIH stakeholders, and other interested 

members of the public to participate and 

provide comments, questions, or 

feedback at the workshop. The goal of 

the meeting is to identify opportunities 

in violence-related research. Public 

input will serve as a valuable element 

in the development of the final 

proposed research opportunities. 

This notice serves as the 

announcement for the fourth and final 

phase of the Scientific Workshop on 

Violence and Related Health Outcomes 

in Sexual and Gender Minority 

Communities. Phase I was the Request 

for Information (RFI) https://

www.federalregister.gov/documents/ 

2020/11/25/2020-26094/request-forinformation-on-research-opportunitiesrelated-to-the-national-institutes-ofhealth published in November 2020. 

The summary of the comments received 

can be found on the https://

dpcpsi.nih.gov/sgmro website. Phase II 

was a session on the state of the science 

for violence research affecting SGM 

communities (a recording will be 


jbell on DSKJLSW7X2PROD with NOTICES